Gunnar Pohl

1.2k total citations
29 papers, 990 citations indexed

About

Gunnar Pohl is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Gunnar Pohl has authored 29 papers receiving a total of 990 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cancer Research, 10 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Gunnar Pohl's work include Protease and Inhibitor Mechanisms (17 papers), Blood Coagulation and Thrombosis Mechanisms (9 papers) and Cell Adhesion Molecules Research (9 papers). Gunnar Pohl is often cited by papers focused on Protease and Inhibitor Mechanisms (17 papers), Blood Coagulation and Thrombosis Mechanisms (9 papers) and Cell Adhesion Molecules Research (9 papers). Gunnar Pohl collaborates with scholars based in Sweden, Germany and Finland. Gunnar Pohl's co-authors include Per Wallén, Nils Bergsdorf, Ulf Sjöbring, Arne Olsén, Hans Jörnvall, Mats Rånby, Hans Joernvall, Tor Ny, Erik Holmgren and Monica Einarsson and has published in prestigious journals such as Biochemistry, Biochemical Journal and FEBS Letters.

In The Last Decade

Gunnar Pohl

28 papers receiving 861 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gunnar Pohl Sweden 14 498 424 263 183 124 29 990
Manfred Hartmann Germany 17 462 0.9× 212 0.5× 117 0.4× 110 0.6× 101 0.8× 38 752
Adolfo Soffientini Italy 18 551 1.1× 392 0.9× 231 0.9× 84 0.5× 35 0.3× 30 1.1k
Carolyn Roitsch France 19 780 1.6× 211 0.5× 514 2.0× 100 0.5× 98 0.8× 36 1.6k
Hirofumi Arimura Japan 13 309 0.6× 184 0.4× 153 0.6× 195 1.1× 55 0.4× 26 687
Terence Cartwright United Kingdom 15 552 1.1× 126 0.3× 60 0.2× 90 0.5× 59 0.5× 41 1.1k
U Seemüller Germany 12 341 0.7× 152 0.4× 168 0.6× 43 0.2× 67 0.5× 15 842
Marina Parry United Kingdom 16 382 0.8× 199 0.5× 245 0.9× 62 0.3× 87 0.7× 34 1.0k
James M. Sodetz United States 26 702 1.4× 228 0.5× 651 2.5× 119 0.7× 113 0.9× 65 2.0k
Gerd Zettlmeißl Germany 20 823 1.7× 74 0.2× 217 0.8× 107 0.6× 188 1.5× 33 1.3k
Erhard Kopetzki Germany 21 574 1.2× 121 0.3× 239 0.9× 76 0.4× 30 0.2× 29 1.1k

Countries citing papers authored by Gunnar Pohl

Since Specialization
Citations

This map shows the geographic impact of Gunnar Pohl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gunnar Pohl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gunnar Pohl more than expected).

Fields of papers citing papers by Gunnar Pohl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gunnar Pohl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gunnar Pohl. The network helps show where Gunnar Pohl may publish in the future.

Co-authorship network of co-authors of Gunnar Pohl

This figure shows the co-authorship network connecting the top 25 collaborators of Gunnar Pohl. A scholar is included among the top collaborators of Gunnar Pohl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gunnar Pohl. Gunnar Pohl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maurer, Christine K., Zhizhou Fang, Christina Schindler, et al.. (2025). In vitro and in vivo ADME of heterobifunctional degraders: a tailored approach to optimize DMPK properties of PROTACs©. RSC Medicinal Chemistry. 16(4). 1746–1757. 6 indexed citations
2.
Björk, Lars, et al.. (1996). Sendai Virus‐Induced IFN‐α Production Analysed by Immunocytochemistry and Computerized Image Analysis. Scandinavian Journal of Immunology. 44(4). 345–353. 10 indexed citations
3.
Cheng, Xiangfei, Gunnar Pohl, Ove Bäck, & Per Wallén. (1996). Characterization of receptors interacting specifically with the B-chain of tissue plasminogen activator on endothelial cells. Fibrinolysis and Proteolysis. 10(3). 167–175. 5 indexed citations
4.
Cheng, Xiangfei, Maria Brohlin, Gunnar Pohl, Ove Bäck, & Per Wallén. (1995). Binding of tissue plasminogen activator to endothelial cells. Thrombosis Research. 77(2). 149–164. 13 indexed citations
6.
Björquist, Petter, Maria Brohlin, Maria Ericsson, et al.. (1994). Plasminogen activator inhibitor type-1 interacts exclusively with the proteinase domain of tissue plasminogen activator. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1209(2). 191–202. 28 indexed citations
7.
Björquist, Petter, et al.. (1994). PAI-1 Binds exclusively to the protease domain of tPA. Fibrinolysis and Proteolysis. 8. 18–18. 1 indexed citations
8.
Wikström, Kristina, Christer Mattsson, & Gunnar Pohl. (1993). A bleeding model in rabbits demonstrate fresh clot selectivity for a genetically engineered variant of tissue-type plasminogen activator and for streptokinase. Thrombosis Research. 70(3). 217–224. 1 indexed citations
9.
Forsberg, G., et al.. (1992). An evaluation of different enzymatic cleavage methods for recombinant fusion proteins, applied on des(1–3)insulin-like growth factor I. Journal of Protein Chemistry. 11(2). 201–211. 35 indexed citations
10.
Holmgren, Erik, Anneli Attersand, Christina Kalderén, et al.. (1991). Synthesis and secretion of a fibrinolytically active tissue-type plasminogen activator variant in Escherichia coli. Gene. 99(2). 243–248. 7 indexed citations
13.
Jalanko, Anu, Jaana Pirhonen, Gunnar Pohl, & Lennart Hansson. (1990). Production of human tissue-type plasminogen activator in different mammalian cell lines using an Epstein-Barr virus vector. Journal of Biotechnology. 15(1-2). 155–168. 8 indexed citations
14.
Olson, H M, Peter Lind, Gunnar Pohl, et al.. (1988). Production of a biologically active variant form of recombinant human secretin. Peptides. 9(2). 301–307. 11 indexed citations
16.
Moks, Tomas, Lars Abrahmsén, Erik Holmgren, et al.. (1987). Expression of human insulin-like growth factor I in bacteria: use of optimized gene fusion vectors to facilitate protein purification. Biochemistry. 26(17). 5239–5244. 118 indexed citations
17.
Pohl, Gunnar, Lennart Kenne, Bo Nilsson, & Monica Einarsson. (1987). Isolation and characterization of three different carbohydrate chains from melanoma tissue plasminogen activator. European Journal of Biochemistry. 170(1-2). 69–75. 52 indexed citations
18.
Norrman, Bo, Gunnar Pohl, Hans Jörnvall, & Per Wallén. (1986). Proteolytically induced variations in the enzymatic properties of tissue plasminogen activator. European Journal of Biochemistry. 159(1). 7–13. 7 indexed citations
19.
Wallén, Per, Gunnar Pohl, Nils Bergsdorf, et al.. (1983). Purification and Characterization of a Melanoma Cell Plasminogen Activator. European Journal of Biochemistry. 132(3). 681–686. 129 indexed citations
20.
Wallén, Per, Gunnar Pohl, Nils Bergsdorf, et al.. (1983). PURIFICATION AND CHARACTERIZATION OF A MELANOMA CELL PLASMINOGEN ACTIVATOR. European Journal of Biochemistry. 132(3). 686–686. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026